US Stock MarketDetailed Quotes

BRNS Barinthus Biotherapeutics

Watchlist

1.430
+0.030+2.14%

Close Jul 1 16:00 ET

1.292
-0.138-9.65%

Pre 08:00 ET

55.82MMarket Cap-781P/E (TTM)

Barinthus Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-272.46%-11.82M

-252.89%-50.93M

-72.82%-19.6M

-194.17%-11.19M

-102.04%-16.96M

51.76%-3.17M

55.71%-14.43M

-42.29%-11.34M

688.90%11.88M

42.61%-8.39M

Net income from continuing operations

14.83%-15.52M

-1,480.32%-73.45M

18.30%-17.29M

-271.63%-14.11M

-251.85%-23.82M

-807.96%-18.22M

110.41%5.32M

-39.50%-21.16M

279.89%8.22M

198.15%15.69M

Operating gains losses

-129.28%-1.03M

129.82%7.53M

-43.01%6.65M

65.69%-6.24M

--3.62M

--3.5M

-432.89%-25.25M

--11.67M

---18.2M

----

Depreciation and amortization

17.12%1.43M

25.58%5.43M

21.92%1.44M

24.07%1.47M

30.95%1.3M

26.40%1.22M

618.11%4.32M

266.67%1.18M

1,297.65%1.19M

853.85%992K

Deferred tax

92.83%-37K

29.10%-3.08M

57.55%-821K

3.68%-602K

-24.15%-1.14M

40.21%-516K

-3,544.54%-4.34M

-3,292.98%-1.93M

-1,983.33%-625K

-12,971.43%-915K

Other non cash items

18.41%431K

21.43%1.41M

191.18%517K

-104.17%-24K

-28.15%554K

-4.96%364K

0.96%1.16M

-262.93%-567K

1,896.88%575K

6,909.09%771K

Change In working capital

-84.43%1.29M

211.71%6.17M

-323.42%-10.88M

-57.91%8.26M

106.06%542K

160.59%8.25M

23.04%-5.52M

-185.47%-2.57M

2,421.54%19.62M

-19.58%-8.95M

-Change in receivables

-104.69%-331K

221.35%5.67M

-270.68%-553K

-108.30%-966K

-68.69%129K

141.42%7.06M

-53.38%-4.68M

145.06%324K

1,290.29%11.64M

168.21%412K

-Change in prepaid assets

-54.16%1.88M

201.38%2.2M

-491.40%-3.05M

-30.25%2.14M

79.93%-983K

464.85%4.09M

48.59%-2.17M

-38.81%779K

82.58%3.07M

27.78%-4.9M

-Change in payables and accrued expense

55.43%-1.35M

-173.24%-1.39M

-112.12%-7.04M

48.21%7.29M

132.26%1.38M

-166.14%-3.02M

112.71%1.89M

-235.00%-3.32M

725.16%4.92M

-12,691.18%-4.28M

-Change in other current assets

--0

133.07%128K

193.06%201K

---211K

108.98%15K

3,175.00%123K

47.35%-387K

-2,063.64%-216K

--0

---167K

-Change in other current liabilities

---346K

---445K

----

--0

----

-Change in other working capital

--1.43M

----

-190.48%-183K

-833.33%-140K

6.25%-15K

90.00%-13K

Cash from discontinued investing activities

Operating cash flow

-272.46%-11.82M

-252.89%-50.93M

-72.82%-19.6M

-194.17%-11.19M

-102.04%-16.96M

51.76%-3.17M

55.71%-14.43M

-42.29%-11.34M

688.90%11.88M

42.61%-8.39M

Investing cash flow

Cash flow from continuing investing activities

87.71%-308K

5.86%-5.41M

126.11%153K

98.22%-36K

-47.18%-3.02M

-129.58%-2.51M

55.47%-5.75M

95.19%-586K

-1,476.56%-2.02M

-916.83%-2.05M

Net PPE purchase and sale

87.71%-308K

5.86%-5.41M

126.11%153K

98.22%-36K

-47.18%-3.02M

-129.58%-2.51M

-401.75%-5.75M

-38.21%-586K

-1,476.56%-2.02M

-916.83%-2.05M

Cash from discontinued investing activities

Investing cash flow

87.71%-308K

5.86%-5.41M

126.11%153K

98.22%-36K

-47.18%-3.02M

-129.58%-2.51M

55.47%-5.75M

95.19%-586K

-1,476.56%-2.02M

-916.83%-2.05M

Financing cash flow

Cash flow from continuing financing activities

-70.22%503K

476.00%1.87M

-77.48%109K

46K

28K

1,162.26%1.69M

-99.85%325K

5,277.78%484K

Net issuance payments of debt

----

--0

----

---159K

--0

Net common stock issuance

-71.88%503K

320.45%2.04M

-77.48%109K

--46K

--91K

--1.79M

-99.53%484K

268.64%484K

--0

Proceeds from stock option exercised by employees

--0

----

Net other financing activities

----

---163K

--0

---63K

---100K

----

Cash from discontinued financing activities

Financing cash flow

-70.22%503K

476.00%1.87M

-77.48%109K

--46K

--28K

1,162.26%1.69M

-99.85%325K

5,277.78%484K

--0

Net cash flow

Beginning cash position

-26.90%142.09M

-9.19%194.39M

-19.89%160.31M

-10.03%173.03M

-4.62%191.33M

-9.19%194.39M

394.74%214.05M

-14.44%200.1M

-21.05%192.33M

28.64%200.6M

Current changes in cash

-191.26%-11.63M

-174.30%-54.47M

-68.99%-19.34M

-213.33%-11.18M

-90.98%-19.95M

49.02%-3.99M

-111.20%-19.86M

43.21%-11.45M

379.25%9.87M

-111.94%-10.45M

Effect of exchange rate changes

-152.62%-492K

1,060.96%2.17M

-80.41%1.12M

26.28%-1.54M

-24.06%1.65M

116.61%935K

102.90%187K

1,604.17%5.73M

66.39%-2.09M

962.44%2.18M

End cash Position

-32.07%129.97M

-26.90%142.09M

-19.89%160.31M

-10.03%173.03M

-4.62%191.33M

-9.19%194.39M

-14.44%200.1M

-21.05%192.33M

Free cash flow

-113.52%-12.13M

-173.90%-56.34M

-63.05%-19.45M

-218.45%-11.23M

-91.25%-19.98M

25.94%-5.68M

39.02%-20.57M

-42.08%-11.93M

541.66%9.48M

29.54%-10.45M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-272.46%-11.82M	-252.89%-50.93M	-72.82%-19.6M	-194.17%-11.19M	-102.04%-16.96M	51.76%-3.17M	55.71%-14.43M	-42.29%-11.34M	688.90%11.88M	42.61%-8.39M
Net income from continuing operations	14.83%-15.52M	-1,480.32%-73.45M	18.30%-17.29M	-271.63%-14.11M	-251.85%-23.82M	-807.96%-18.22M	110.41%5.32M	-39.50%-21.16M	279.89%8.22M	198.15%15.69M
Operating gains losses	-129.28%-1.03M	129.82%7.53M	-43.01%6.65M	65.69%-6.24M	--3.62M	--3.5M	-432.89%-25.25M	--11.67M	---18.2M	----
Depreciation and amortization	17.12%1.43M	25.58%5.43M	21.92%1.44M	24.07%1.47M	30.95%1.3M	26.40%1.22M	618.11%4.32M	266.67%1.18M	1,297.65%1.19M	853.85%992K
Deferred tax	92.83%-37K	29.10%-3.08M	57.55%-821K	3.68%-602K	-24.15%-1.14M	40.21%-516K	-3,544.54%-4.34M	-3,292.98%-1.93M	-1,983.33%-625K	-12,971.43%-915K
Other non cash items	18.41%431K	21.43%1.41M	191.18%517K	-104.17%-24K	-28.15%554K	-4.96%364K	0.96%1.16M	-262.93%-567K	1,896.88%575K	6,909.09%771K
Change In working capital	-84.43%1.29M	211.71%6.17M	-323.42%-10.88M	-57.91%8.26M	106.06%542K	160.59%8.25M	23.04%-5.52M	-185.47%-2.57M	2,421.54%19.62M	-19.58%-8.95M
-Change in receivables	-104.69%-331K	221.35%5.67M	-270.68%-553K	-108.30%-966K	-68.69%129K	141.42%7.06M	-53.38%-4.68M	145.06%324K	1,290.29%11.64M	168.21%412K
-Change in prepaid assets	-54.16%1.88M	201.38%2.2M	-491.40%-3.05M	-30.25%2.14M	79.93%-983K	464.85%4.09M	48.59%-2.17M	-38.81%779K	82.58%3.07M	27.78%-4.9M
-Change in payables and accrued expense	55.43%-1.35M	-173.24%-1.39M	-112.12%-7.04M	48.21%7.29M	132.26%1.38M	-166.14%-3.02M	112.71%1.89M	-235.00%-3.32M	725.16%4.92M	-12,691.18%-4.28M
-Change in other current assets	--0	133.07%128K	193.06%201K	---211K	108.98%15K	3,175.00%123K	47.35%-387K	-2,063.64%-216K	--0	---167K
-Change in other current liabilities	---346K	---445K	----	----	----	--0	--0	----	----	----
-Change in other working capital	--1.43M	----	----	----	----	----	-190.48%-183K	-833.33%-140K	6.25%-15K	90.00%-13K
Cash from discontinued investing activities
Operating cash flow	-272.46%-11.82M	-252.89%-50.93M	-72.82%-19.6M	-194.17%-11.19M	-102.04%-16.96M	51.76%-3.17M	55.71%-14.43M	-42.29%-11.34M	688.90%11.88M	42.61%-8.39M
Investing cash flow
Cash flow from continuing investing activities	87.71%-308K	5.86%-5.41M	126.11%153K	98.22%-36K	-47.18%-3.02M	-129.58%-2.51M	55.47%-5.75M	95.19%-586K	-1,476.56%-2.02M	-916.83%-2.05M
Net PPE purchase and sale	87.71%-308K	5.86%-5.41M	126.11%153K	98.22%-36K	-47.18%-3.02M	-129.58%-2.51M	-401.75%-5.75M	-38.21%-586K	-1,476.56%-2.02M	-916.83%-2.05M
Cash from discontinued investing activities
Investing cash flow	87.71%-308K	5.86%-5.41M	126.11%153K	98.22%-36K	-47.18%-3.02M	-129.58%-2.51M	55.47%-5.75M	95.19%-586K	-1,476.56%-2.02M	-916.83%-2.05M
Financing cash flow
Cash flow from continuing financing activities	-70.22%503K	476.00%1.87M	-77.48%109K	46K	28K	1,162.26%1.69M	-99.85%325K	5,277.78%484K	0	0
Net issuance payments of debt	----	--0	--0	--0	----	----	---159K	--0	--0	--0
Net common stock issuance	-71.88%503K	320.45%2.04M	-77.48%109K	--46K	--91K	--1.79M	-99.53%484K	268.64%484K	--0	--0
Proceeds from stock option exercised by employees	--0	--0	--0	--0	--0	--0	--0	--0	--0	----
Net other financing activities	----	---163K	--0	--0	---63K	---100K	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-70.22%503K	476.00%1.87M	-77.48%109K	--46K	--28K	1,162.26%1.69M	-99.85%325K	5,277.78%484K	--0	--0
Net cash flow
Beginning cash position	-26.90%142.09M	-9.19%194.39M	-19.89%160.31M	-10.03%173.03M	-4.62%191.33M	-9.19%194.39M	394.74%214.05M	-14.44%200.1M	-21.05%192.33M	28.64%200.6M
Current changes in cash	-191.26%-11.63M	-174.30%-54.47M	-68.99%-19.34M	-213.33%-11.18M	-90.98%-19.95M	49.02%-3.99M	-111.20%-19.86M	43.21%-11.45M	379.25%9.87M	-111.94%-10.45M
Effect of exchange rate changes	-152.62%-492K	1,060.96%2.17M	-80.41%1.12M	26.28%-1.54M	-24.06%1.65M	116.61%935K	102.90%187K	1,604.17%5.73M	66.39%-2.09M	962.44%2.18M
End cash Position	-32.07%129.97M	-26.90%142.09M	-26.90%142.09M	-19.89%160.31M	-10.03%173.03M	-4.62%191.33M	-9.19%194.39M	-9.19%194.39M	-14.44%200.1M	-21.05%192.33M
Free cash flow	-113.52%-12.13M	-173.90%-56.34M	-63.05%-19.45M	-218.45%-11.23M	-91.25%-19.98M	25.94%-5.68M	39.02%-20.57M	-42.08%-11.93M	541.66%9.48M	29.54%-10.45M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall